How Do Life Sciences Companies Keep Content Compliant?
Maintaining content compliance in the life sciences sector, particularly in pharmaceuticals, is a huge and complex challenge with potentially serious financial, legal and human health consequences if not addressed as part of a high priority global content strategy.
In episode three of Close the Content Loop, Emerson and Sam are joined by special guest Dr. Ray Glemser, chair and co-founder of Glemser Technologies, to get a real insight into the interactions between health authorities and pharmaceutical companies and explore the myriad of regulatory processes they go through to keep labels, instructions and other critical content compliant.Watch Video
Close the Content Loop is our monthly webinar series about all things enterprise content creation, automation and intelligence. It features interviews with experts in content lifecycle management from a variety of industries and job roles.
Dr. Ray Glemser
Chair, Glemser Technologies
Ray Glemser is Chair and co-founder of Glemser Technologies (www.glemser.com), which provides process and technology solutions and services for life science companies to improve product quality, comply with regulatory requirements and gain operational efficiencies. He serves as a strategic advisor to clients and partners strategies for enterprise-wide technology, process optimization, revenue creation, compliance improvement and realization of returns on investment based on 35 years of successfully deploying global solutions.
Dr. Glemser received his PhD degree in Industrial Engineering from Lehigh University and has since received the Ben Franklin Innovation Award for Entrepreneurial Achievement in 2002 for creating and retaining high-tech jobs in Pennsylvania in a highly dynamic and challenging business environment.